Evidence map›Paper›PMID 24931675›Full record

ArticleJournal of theoretical biology2014

Derivation and experimental comparison of cell-division probability densities.

R Leander, E J Allen, S P Garbett, D R Tyson, V Quaranta

Abstract readComparative Study
In one paragraph

Article in Journal of theoretical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Comparison of Drug Inhibitory Effects (Bulletin of mathematical biology · 2020
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R LeanderDepartment of Mathematical Sciences, Middle Tennessee State University, Murfreesboro, TN 37132, United States. Electronic address: rachel.leander@mtsu.edu.
E J AllenDepartment of Mathematics and Statistics, Texas Tech University, Lubbock, TX 79409, United States. Electronic address: edward.allen@ttu.edu.
S P GarbettVanderbilt-Ingram Cancer Center, 771 Preston Building, 2220 Pierce Avenue, Nashville, TN 37232, United States. Electronic address: shawn.garbett@vanderbilt.edu.
D R TysonVanderbilt-Ingram Cancer Center, 771 Preston Building, 2220 Pierce Avenue, Nashville, TN 37232, United States. Electronic address: darren.tyson@vanderbilt.edu.
V QuarantaVanderbilt-Ingram Cancer Center, 771 Preston Building, 2220 Pierce Avenue, Nashville, TN 37232, United States. Electronic address: vito.quaranta@vanderbilt.edu.

Funding

TrainingU54CA113007 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO · 2004 to 2014
$19.2M
Evaluation and Validation of Imaging Biomarkers of Tumor Response to TreatmentR01CA138599 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MCINTYRE, JAMES OLIVER · 2010 to 2015
$2.2M
Inhibition of proliferation by LamininR21CA178589 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO · 2014 to 2015
$375k
NCI NIH HHS U54 CA113007
6 · The paper itself

Abstract

Experiments have shown that, even in a homogeneous population of cells, the distribution of division times is highly variable. In addition, a homogeneous population of cells will exhibit a heterogeneous response to drug therapy. We present a simple stochastic model of the cell cycle as a multistep stochastic process. The model, which is based on our conception of the cell cycle checkpoint, is used to derive an analytical expression for the distribution of cell cycle times. We demonstrate that this distribution provides an accurate representation of cell cycle time variability and show how the model relates drug-induced changes in basic biological parameters to variability in response to drug treatment.

Indexed as

Models, TheoreticalAntineoplastic AgentsCell CountCell CycleCell DivisionCell ProliferationCycloheximideDimethyl SulfoxideErlotinib HydrochlorideHumansNeoplasmsProbabilityQuinazolinesStochastic ProcessesAntineoplastic AgentsCycloheximideDimethyl SulfoxideErlotinib HydrochlorideQuinazolinesFirst exit timeIntermitotic timeMathematical modelingStochastic differential equation

Identifiers

PMID24931675
PMCPMC5488810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.